Skip to content

STTK

Shattuck Labs, Inc.

NASDAQ · Healthcare · Biotechnology · US

$6.01
+2.74%
Ask drillr
0
Insider buys (3m)
4
Insider sells (3m)
-$379.3K
Net value (3m)
+14.3%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 7, 2026Shukla Abhinav A. · officer: Chief Technical OfficerSale410$7.01
Jul 7, 2026Shukla Abhinav A. · officer: Chief Technical OfficerM-Exempt12,153$3.57
Jul 7, 2026Shukla Abhinav A. · officer: Chief Technical OfficerM-Exempt410$3.57
Jul 2, 2026Shukla Abhinav A. · officer: Chief Technical OfficerSale23,365$7.08
Jul 2, 2026Shukla Abhinav A. · officer: Chief Technical OfficerM-Exempt23,365$3.57
Jul 2, 2026Pandite Arundathy N. · officer: Chief Medical OfficerSale30,000$7.01
Jul 2, 2026Shukla Abhinav A. · officer: Chief Technical OfficerSale100$7.07
Jul 2, 2026Shukla Abhinav A. · officer: Chief Technical OfficerM-Exempt100$3.57
Jun 15, 2026ORBIMED ADVISORS LLC · directorPurchase208,333$0.00
Jun 15, 2026ORBIMED ADVISORS LLC · directorPurchase1,041,667$0.00
Jun 15, 2026Ashiya Mona · directorPurchase208,333$0.00
Jun 15, 2026Ashiya Mona · directorPurchase1,041,667$0.00
Jun 11, 2026SIEGALL CLAY B · directorPurchase62,500$4.00
Jun 2, 2026Boudreau Helen M · directorA-Award81,000$5.95
Jun 2, 2026SIEGALL CLAY B · directorA-Award81,000$5.95
Jun 2, 2026Ashiya Mona · directorA-Award81,000$5.95
Jun 2, 2026Gibson Neil W · directorA-Award81,000$5.95
Jun 2, 2026Golumbeski George · directorA-Award81,000$5.95
Jun 2, 2026Baker Daniel G. · directorA-Award81,000$5.95
May 27, 2026SIEGALL CLAY B · directorA-Award128,054$1.08
May 27, 2026SIEGALL CLAY B · directorM-Exempt128,054$1.08
May 21, 2026Shukla Abhinav A. · officer: Chief Technical OfficerM-Exempt5,122$1.08
May 21, 2026Shukla Abhinav A. · officer: Chief Technical OfficerA-Award5,122$1.08
May 18, 2026Stout Stephen · officer: See RemarksM-Exempt12,805$1.08
May 18, 2026Stout Stephen · officer: See RemarksA-Award12,805$1.08
May 14, 2026Shukla Abhinav A. · officer: Chief Technical OfficerSale2,032$7.01
May 14, 2026Pandite Arundathy N. · officer: Chief Medical OfficerSale30,000$6.61
May 14, 2026Neill Andrew R · officer: Chief Financial OfficerA-Award64,027$1.08
May 14, 2026Neill Andrew R · officer: Chief Financial OfficerM-Exempt64,027$1.08
May 14, 2026Shukla Abhinav A. · officer: Chief Technical OfficerM-Exempt2,032$3.57
Institutional positioning

13F filings over the trailing two quarters

New 62Increased 69Reduced 32Sold out 18
FilerActionSharesFiled
T. Rowe Price Investment Management, Inc.Increased13,432,540Aug 14, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.Increased9,865,558May 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Increased8,122,179Aug 14, 2026
Redmile Group, LLCIncreased6,892,033Aug 14, 2026
ORBIMED ADVISORS LLCUnchanged6,306,127Aug 14, 2026
ORBIMED ADVISORS LLCUnchanged6,306,127May 15, 2026
Prosight Management, LPIncreased5,957,877Aug 14, 2026
REDMILE GROUP, LLCUnchanged5,539,724May 15, 2026
PROSIGHT MANAGEMENT, LPIncreased5,004,439May 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Reduced4,644,957May 15, 2026
BlackRock, Inc.Increased3,935,810Aug 7, 2026
Frazier Life Sciences Management, L.P.New Position3,750,000Aug 14, 2026
NEXTBio Capital Management LPIncreased3,727,348Aug 14, 2026
Deep Track Capital, LPNew Position3,706,734Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased3,207,865Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 7, 2026